Vanessa Schmidt (0000-0001-5460-6217)

Personal information

Biography

Vanessa qualified in 1994 at Queensland University, Brisbane, Australia before travelling to the UK. After several years in both mixed and small animal practice, she gained the European diploma of Veterinary Dermatology in 2009 and was granted RCVS specialisation in 2014. She also obtained her PhD in 2014, following four years of research into antimicrobial resistance amongst canine staphylococci and E. coli.

Activities

Collapse all

University of Liverpool School of Veterinary Science: Leahurst, Liverpool, GB

2014-04-01 to present | Senior Lecturer in Veterinary Science (School of Veternary Science)

Employment

Vanessa Schmidt

https://orcid.org/0000-0001-5460-6217

Personal information

Emails & domains

Verified email domains

Websites & social links

Other IDs

Keywords

Biography

Activities

Employment (1)

University of Liverpool School of Veterinary Science: Leahurst, Liverpool, GB

Education and qualifications (4)

University of Liverpool: Liverpool, Merseyside, GB

University of Liverpool School of Veterinary Science: Leahurst, Liverpool, GB

University of Liverpool: Leahurst, Liverpool, GB

University of Queensland School of Veterinary Science: Brisbane, QLD, AU

Professional activities (3)

Royal Veterinary College: London, GB

European Society of Veterinary Dermatology: Liverpool , DE

RCVS: London, GB

Funding (9)

Microbiome-derived therapeutics for canine dermatitis

Exploring the dog microbiome for therapeutic potential in the treatment of canine bacteria pyoderma

Efficacy of environmental microfibre and steam-cleaning technology for removal of bacterial pathogens in veterinary hospitals

An investigation into the antimicrobial properties of canine skin microflora

Characterising the bacterial flora associated with otitis externa in atopic dogs  a pilot study

Does feeding raw meat diets expose our pets and households to antimicrobial resistant bacterial pathogens?

A topical bioactive moisturiser for canine atopic dermatitis: the dawn of a new era for primary prevention?

Canine raw meat diets

CBD-containing drug delivery systems as a novel therapy in dogs with atopic Dermatitis

Works (36)

The Potential of Cannabidiol for Treating Canine Atopic Dermatitis

Raw meat diets are a major risk factor for carriage of third-generation cephalosporin-resistant and multidrug-resistant E. coli by dogs in the UK

Proliferative, lymphocytic, infundibular mural folliculitis and dermatitis with prominent follicular apoptosis and parakeratotic casts in a Labrador retriever: Clinical, histopathological and dermoscopic features and co‐morbidities

Rapid typing of Klebsiella pneumoniae and Pseudomonas aeruginosa by Fourier-transform Infrared spectroscopy informs infection control in veterinary settings

Mastocytosis in the skin in dogs: A multicentric case series

An investigation of the presence and antimicrobial susceptibility of Enterobacteriaceae in raw and cooked kibble diets for dogs in the UK

Canine cutaneous lupus erythematosus with prominent interdigital lesions in two greyhounds

Diagnosis and treatment of dermatophytic furunculosis in a polar bear (<i>Ursus maritimus</i>)

Challenging the norm: Epicutaneous immunotherapy for canine atopic dermatitis

Primary Prevention of Canine Atopic Dermatitis: Breaking the Cycle—A Narrative Review

Resistome-based surveillance identifies ESKAPE pathogens as the predominant gram-negative organisms circulating in veterinary hospitals

INCREASED TOLERANCE TO CHLORHEXIDINE FOLLOWING PROLONGED EXPOSURE IN STAPHYLOCOCCUS SPECIES ISOLATED FROM THE SKIN AND MUCOSAE OF DOGS

A Dog’s Dinner: Factors affecting food choice and feeding practices for UK dog owners feeding raw meat-based or conventional cooked diets

UK dogs eating raw meat diets have higher risk of Salmonella and antimicrobial‐resistant Escherichia coli faecal carriage

Geographical Variations in Virulence Factors and Antimicrobial Resistance Amongst Staphylococci Isolated From Dogs From the United Kingdom and Romania

Reservoirs of resistance: polymyxin resistance in veterinary-associated companion animal isolates of <i>Pseudomonas aeruginosa</i>.

Diversity, Virulence, and Clinical Significance of Extended-Spectrum β-Lactamase- and pAmpC-Producing <i>Escherichia coli</i> From Companion Animals.

Genetic resistance determinants to fusidic acid and chlorhexidine in variably susceptible staphylococci from dogs.

Routine antibiotic therapy in dogs increases the detection of antimicrobial-resistant faecal Escherichia coli.

Are the Hands of Veterinary Staff a Reservoir for Antimicrobial-Resistant Bacteria? A Randomized Study to Evaluate Two Hand Hygiene Rubs in a Veterinary Hospital.

Successful multimodal treatment of Paecilomyces lilacinus infection in a dog

Impact of systemic antimicrobial therapy on mucosal staphylococci in a population of dogs in Northwest England.

Small animal disease surveillance: pruritus, and coagulase‐positive staphylococci

Interaction of chlorhexidine with trisEDTA or miconazole in vitro against canine meticillin-resistant and -susceptible Staphylococcus pseudintermedius isolates from two UK regions.

Veterinary Hospital Dissemination of CTX-M-15 Extended-Spectrum Beta-Lactamase-Producing Escherichia coli ST410 in the United Kingdom.

A pilot study comparing in vitro efficacy of topical preparations against veterinary pathogens.

Efficacy of proactive long-term maintenance therapy of canine atopic dermatitis with 0.0584% hydrocortisone aceponate spray: a double-blind placebo controlled pilot study.

Antimicrobial resistance risk factors and characterisation of faecal E. coli isolated from healthy Labrador retrievers in the United Kingdom.

Antimicrobial resistance and characterisation of staphylococci isolated from healthy Labrador retrievers in the United Kingdom.

Cross-reaction and co-sensitization among related and unrelated allergens in canine intradermal tests.

Does Confirmed Pathogen Transfer between Sanctuary Workers and Great Apes Mean that Reintroduction Should not Occur?

Efficacy of a 0.0584% hydrocortisone aceponate spray in presumed feline allergic dermatitis: an open label pilot study.

The glucocorticoid sparing efficacy of Phytopica in the management of canine atopic dermatitis.

Staphylococcus intermedius binding to immobilized fibrinogen, fibronectin and cytokeratin in vitro.

Staphylococcal colonization of mucosal and lesional skin sites in atopic and healthy dogs.

Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.

Characterising the bacterial flora associated with otitis externa in atopic dogs a pilot study